InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 7,712 decisions over 12 months
Reset filters
Direction ?
Both7,712 Bought1,461 Sold6,251
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Plan: Discretionary Minimum: $1M
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
SCHW Charles Schwab Corporation
23 Apr 2026
Schwab Charles R.
Co-Chairman indirect
Sold at will
36,450
$3.30M
0.1%
ESTA ESTABLISHMENT LABS HOLDINGS INC.
23 Apr 2026
Chacon Quiros Juan Jose
Director indirect
Sold at will 4×
42,642
$2.79M
3.6%
SEIC SEI INVESTMENTS CO
23 Apr 2026
Sharma Sanjay
See Remarks*
Sold at will 2×
25,000
$2.25M
38.6%
VICR VICOR CORP
23 Apr 2026
Doyle Alvaro
VP and CIO
Sold at will 2×
8,000
$2.08M
99.5%
BANF BANCFIRST CORP /OK/
23 Apr 2026
RAINBOLT DAVID E
Director indirect
Sold at will
17,527
$2.02M
7.8%
TORO TORO CORP.
23 Apr 2026
Panagiotidis Petros Panagiotis
Chief Executive Officer indirect
Bought
265,836
$1.73M
1.3%
PSMT PRICESMART INC
23 Apr 2026
PRICE ROBERT E
Director indirect
Sold at will
10,000
$1.62M
7.1%
NNBR NN INC
23 Apr 2026
Corre Partners Management, LLC
10% owner indirect
Sold at will 2×
555,305
$1.49M
57.4%
NNBR NN INC
23 Apr 2026
Barrett John Frederick
10% owner indirect
Sold at will
555,305
$1.49M
10.5%
SEIC SEI INVESTMENTS CO
23 Apr 2026
McCabe Philip
See Remarks
Sold at will
15,000
$1.38M
21.5%
ACRS Aclaris Therapeutics, Inc.
23 Apr 2026
Leonard Braden Michael
10% owner indirect
Sold at will
300,000
$1.36M
2.1%
STLD Steel Dynamics
23 Apr 2026
Cornew Kenneth W.
Director
Sold at will 2×
5,000
$1.12M
13.8%
STLD Steel Dynamics
23 Apr 2026
Alvarez Miguel
Senior Vice President
Sold at will 3×
4,825
$1.09M
3.8%
GS Goldman Sachs
23 Apr 2026
GOLTEN ALEX S
CHIEF RISK OFFICER
Sold at will 2×
1,116
$1.04M
30.2%
CAR AVIS BUDGET GROUP, INC.
22 Apr 2026
Pentwater Capital Management LP
10% owner indirect
Sold at will 31×
1,647,000
$1.02B
21.1%
CRWV CoreWeave, Inc.
22 Apr 2026
Magnetar Financial LLC
10% owner indirect
Sold at will 84×
2,439,208
$297.92M
90.0%
RDW Redwire Corp
22 Apr 2026
AE RED HOLDINGS, LLC
Director indirect
Sold at will
21,365,909
$231.82M
99.4%
TORO TORO CORP.
22 Apr 2026
Panagiotidis Petros Panagiotis
Chief Executive Officer indirect
Bought 2×
1,982,728
$12.06M
10.7%
PAM Pampa Energy Inc.
22 Apr 2026
Mindlin Marcos Marcelo
Director
Sold at will
1,500,000
$5.27M
5.7%
ASX ASE Technology Holding Co., Ltd.
22 Apr 2026
Chen Jeffrey
Director indirect
Sold at will
9,000
$4.20M
8.2%
VOR Vor Biopharma Inc.
22 Apr 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will
165,150
$2.60M
6.4%
MXF MEXICO FUND INC
22 Apr 2026
Saba Capital Management, L.P.
10% owner indirect
Bought
100,000
$2.18M
5.6%
FLWS 1 800 FLOWERS COM INC
22 Apr 2026
Fund 1 Investments, LLC
10% owner indirect
Sold at will 5×
489,238
$2.04M
11.9%
AEHR AEHR TEST SYSTEMS
22 Apr 2026
POSEDEL RHEA J
Director
Sold at will
17,115
$1.71M
27.4%
PSMT PRICESMART INC
22 Apr 2026
PRICE ROBERT E
Director indirect
Sold at will
10,000
$1.60M
6.6%
STT State Street Corporation
22 Apr 2026
TAHIRI MOSTAPHA
EVP and COO
Sold at will
9,611
$1.47M
12.9%
KNTK Kinetik Holdings Inc.
22 Apr 2026
ISQ Global Fund II GP LLC
10% owner indirect
Sold at will
21,429
$1.03M
1.4%
SMR NUSCALE POWER Corp
21 Apr 2026
FLUOR CORP
Director indirect
Sold at will
13,500,000
$159.42M
100%
CRWV CoreWeave, Inc.
21 Apr 2026
Magnetar Financial LLC
10% owner indirect
Sold at will 12×
323,452
$38.25M
53.6%
PRLD Prelude Therapeutics Inc
21 Apr 2026
ORBIMED ADVISORS LLC
Director indirect
Bought 2×
2,815,315
$12.50M
31.3%
PRLD Prelude Therapeutics Inc
21 Apr 2026
Bonita David P
Director indirect
Bought 2×
2,815,315
$12.50M
31.3%
RDW Redwire Corp
21 Apr 2026
AE RED HOLDINGS, LLC
Director indirect
Sold at will
977,887
$10.34M
4.4%
SBC SBC Medical Group Holdings Inc
21 Apr 2026
Aikawa Yoshiyuki
Chairman and CEO
Sold at will
3,100,000
$9.37M
3.8%
AGX ARGAN INC
21 Apr 2026
Collins Charles Edwin IV
CHIEF EXECUTIVE OFFICER, GEMMA
Sold at will
11,068
$6.88M
26.7%
AEHR AEHR TEST SYSTEMS
21 Apr 2026
SCOTT GEOFFREY GATES
Director indirect
Sold at will 2×
60,000
$5.66M
54.5%
CACC CREDIT ACCEPTANCE CORP
21 Apr 2026
Watson Jill Foss
10% owner indirect
Sold at will 12×
9,450
$5.09M
9.3%
ASX ASE Technology Holding Co., Ltd.
21 Apr 2026
Chen Jeffrey
Director indirect
Sold at will
9,000
$4.17M
7.6%
FLWS 1 800 FLOWERS COM INC
21 Apr 2026
Fund 1 Investments, LLC
10% owner indirect
Sold at will 5×
720,000
$3.02M
14.9%
LEVI LEVI STRAUSS & CO
21 Apr 2026
Singh Harmit J
EVP & Chief Fin. & Growth Ofc.
Sold at will
121,767
$2.86M
45.0%
USB U.S. Bancorp
21 Apr 2026
Richard Jodi L
Vice Chair
Sold at will
40,000
$2.28M
16.2%
AGX ARGAN INC
21 Apr 2026
Jeffrey John Ronald Jr.
Director
Sold at will
3,636
$2.24M
100%
AEHR AEHR TEST SYSTEMS
21 Apr 2026
SALAMONE ALBERTO
EVP, PPBI BUSINESS
Sold at will
15,000
$1.42M
23.8%
IBN ICICI BANK LTD
21 Apr 2026
Jha Rakesh
Director
Sold at will
90,000
$1.34M
39.0%
ASX ASE Technology Holding Co., Ltd.
20 Apr 2026
Chen Tien-Szu
GM, ASE Inc. Chung-Li Branch
Sold at will 4×
530,000
$247.14M
19.1%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Kaplan Andrew T.
Director indirect
Bought
8,398,438
$134.38M
47.0%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
BAIN CAPITAL INVESTORS LLC
10% owner indirect
Bought
8,398,438
$134.38M
47.0%
TRAX First Tracks Biotherapeutics, Inc.
20 Apr 2026
EcoR1 Capital, LLC
10% owner indirect
Bought
4,705,575
$65.00M
opened
CRWV CoreWeave, Inc.
20 Apr 2026
Magnetar Financial LLC
10% owner indirect
Sold at will 12×
319,835
$37.53M
53.3%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Bain Capital Life Sciences Investors, LLC
10% owner indirect
Bought
1,562,500
$25.00M
7.4%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Koppel Adam
Director indirect
Bought
1,562,500
$25.00M
7.4%
Showing 3,501–3,550 of 7,712. ← Newer Page 71 of 155 Older →